Supreme Court: Rejects India HPV Vaccine PIL on Consent, Autonomy

• The Supreme Court of India rejected a Public Interest Litigation challenging the nationwide Human Papillomavirus (HPV) Vaccination Programme on September 10, 2026.
• Filed by the Universal Health Organisation (UHO), the PIL alleged the program lacked proper informed consent, transparent adverse event reporting, and a vaccine injury compensation scheme.
• The UHO contended that the program's implementation violated constitutional rights under Articles 14 and 21, citing principles of bodily integrity and informed consent.
• The petition specifically highlighted concerns about school-based vaccinations, the absence of an India-specific AEFI dashboard, and the lack of a statutory vaccine injury compensation framework.
• Justice Joymalya Bagchi reportedly advised the petitioner's counsel to withdraw the PIL, stating there should be "No special treatment for one case where adverse effects are seen."

The PIL, brought under Article 32 of the Constitution, aimed to ensure the program adhered to constitutional guarantees of informed consent, bodily autonomy, transparency, and accountability.

The Supreme Court of India recently dismissed a Public Interest Litigation (PIL) that sought to challenge the implementation and constitutional validity of the nationwide Human Papillomavirus (HPV) Vaccination Programme. On September 10, 2026, the apex court rejected the petition filed by the Universal Health Organisation (UHO) through its Chairperson, Dr. Amitav Banerjee. The PIL, brought under Article 32 of the Constitution, aimed to ensure the program adhered to constitutional guarantees of informed consent, bodily autonomy, transparency, and accountability.

Represented by Supreme Court Advocate Shivam Raghuwanshi, the UHO contended that the existing implementation of the India HPV vaccination program challenge suffered from significant constitutional and procedural shortcomings. During the proceedings, Justice Joymalya Bagchi reportedly instructed the petitioner's counsel to withdraw the PIL, stating that "No special treatment for one case where adverse effects are seen." This directive underscored the Court's view on the broad challenge presented.

The Universal Health Organisation PIL India specifically alleged that the nationwide HPV vaccination program was introduced without a legally sound framework for informed consent. The petition highlighted a lack of adequate disclosure regarding potential risks and available alternatives to parents and guardians. Furthermore, it pointed to the absence of a transparent mechanism for reporting adverse events and the complete omission of a vaccine injury compensation scheme. These alleged deficiencies, according to the UHO, constituted violations of the constitutional rights of both parents and minor children, specifically citing Articles 14 and 21 of the Constitution.

The petitioner detailed several critical issues presented to the Supreme Court. These included the alleged absence of standardized written informed parental consent prior to vaccination, and concerns that school-based vaccination programs could inadvertently create institutional pressure, thereby compromising the voluntary nature of consent. The PIL also noted the lack of a publicly accessible, India-specific dashboard for Adverse Events Following Immunisation (AEFI) related to the HPV program. Additionally, the absence of a statutory Vaccine Injury Compensation Scheme, despite such practices being common internationally, was a significant point of contention. Finally, the UHO raised concerns about the insufficient availability of consent materials in regional languages, which could hinder meaningful informed decision-making by parents.

Central to the Universal Health Organisation's challenge was the assertion that bodily integrity, informed consent, and the right to refuse medical treatment are fundamental aspects of Article 21, which guarantees the protection of life and personal liberty. The PIL drew upon established constitutional principles articulated by the Supreme Court in landmark judgments such as *Justice K.S. Puttaswamy v. Union of India*, *Aruna Ramachandra Shanbaug v. Union of India*, and notably, *Jacob Puliyel v. Union of India*, to bolster its arguments regarding HPV vaccine informed consent India. These precedents underscore the importance of individual autonomy in medical decisions.

The petition also referenced the 72nd Report of the Parliamentary Standing Committee from 2013, which had previously investigated alleged irregularities concerning the earlier PATH HPV demonstration project. By citing this report, the UHO aimed to emphasize that similar concerns regarding informed consent should not be permitted to re-emerge during the current nationwide rollout of the HPV vaccination program. The petitioner maintained that constitutional rights and public health objectives are not mutually exclusive but rather complementary, advocating for a public health approach that fully respects individual liberties and due process.

In light of the identified deficiencies, the PIL put forth several specific prayers for judicial intervention. The UHO requested the suspension of the school-based component of the HPV Vaccination Programme until a legally compliant informed consent protocol could be established. It also sought the constitution of an independent expert committee tasked with examining epidemiological data, vaccine safety, existing consent practices, and available alternatives to the current program.

Further demands included the establishment of a real-time public AEFI surveillance dashboard to enhance transparency and monitoring of the HPV vaccine. The petition also called for the notification of a national Vaccine Injury Compensation Scheme, addressing the current void in vaccine injury compensation India law. Finally, the UHO urged the formulation of a comprehensive Vaccine Consent Framework specifically designed to govern the vaccination of minors across India, ensuring robust protections for children and their parents.

Source: Original reporting via Aishwarya Iyer